Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27,407,170
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
5,703,056
-
Shares change
-
+240,388
-
Total reported value, excl. options
-
$44,310,000
-
Value change
-
+$2,005,247
-
Number of buys
-
28
-
Number of sells
-
-21
-
Price
-
$7.77
Significant Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q4 2019
65 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q4 2019.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,703,056 shares
of 27,407,170 outstanding shares and own 20.81% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (861,118 shares), RENAISSANCE TECHNOLOGIES LLC (603,270 shares), Parkman Healthcare Partners LLC (600,686 shares), G2 Investment Partners Management LLC (574,930 shares), Fairpointe Capital LLC (441,157 shares), BlackRock Inc. (433,763 shares), EAM Investors, LLC (350,880 shares), EAM Global Investors LLC (214,659 shares), GEODE CAPITAL MANAGEMENT, LLC (138,635 shares), and OXFORD ASSET MANAGEMENT LLP (114,022 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.